I-INNOVITA, okuwukuphela kwenkampani yokuxilonga ye-In-vitro esifundazweni sase-Hebei, iwine ukuhlonishwa kwezwe

NgoSepthemba 2020, i-Innovita (Tangshan) Biotechnology Co., Ltd.(INNOVITA) yanconywa njengeqembu elithuthukile emzabalazweni wesizwe wokulwa nobhubhane lwe-Covid-19.Lena ukuphela kwenkampani yokuxilonga ye-In-vitro esifundazweni sase-Hebei ethole lolu dumo.

“Ngemuva kokugqashuka kobhubhane lwe-Covid-19, i-Innovita (Tangshan) Biotechnology Co., Ltd. yathatha isinyathelo ngokushesha ukuze isebenzise izinzuzo zobuchwepheshe zokugxila ezinkingeni zokuxilonga izifo ezithathelanayo zokuphefumula iminyaka eminingi, futhi yathumela ngokushesha abakhethiweyo ukuthi bayenze. ucwaningo lwesayensi.”U-INNOVITA wethulwa.

I-INNOVITA inethimba labacwaningi besayensi elakhiwe oPhD kanye nabasebenzi abangochwepheshe abaphezulu.Wonke amalungu ethimba le-R&D ayeke amaholide awo abuyela esikhungweni senkampani se-R&D esuka ezindaweni ezihlukahlukene, abuyela emsebenzini ngokushesha okukhulu, futhi azinikela ocwaningweni nasekuthuthukiseni izinto ezisiza ukuhlonza i-Covid-19.Ukugijima ngokumelene nesikhathi, ukugijima ngokumelene negciwane elisakazeka ngokushesha, ukuthembela enzuzweni yezobuchwepheshe yama-reagents okuhlola ukuphefumula, ukubeka engcupheni yokutheleleka ngegciwane, kanye nokunqoba ubunzima kusukela ekuhlolweni kwempahla eluhlaza kanye nokwenza ngcono inqubo, kuya ekuqinisekisweni komtholampilo, i-INNOVITA ithuthukise ngempumelelo i-2019-nCoV Antibody. Ikhithi Yokuhlola.

Ngomhla ziyisi-9 kuFebhuwari, 2020, umkhiqizo waphasisa ukuvikela uchwepheshe beNational Food and Drug Administration.Ngomhla ziyi-11 kuNhlolanja, ikhonjwe njengohlelo olubalulekile lukazwelonke locwaningo olwenziwe nguMnyango Wezesayensi Nobuchwepheshe.NgoFebhuwari 22, i-INNOVITA yathuthukisa uhlobo olusha lwekhithi yokuhlola i-antibody ye-2019-nCoV, eyagqama emikhiqizweni eminingi esimenyezelwe ezweni futhi yaba ngeyokuqala yezinkampani ezimbili ezweni ukuthola isitifiketi sokubhalisa sokuhlolwa kwe-antibody ye-Covid-19. ama-reagents.Ochwepheshe abadumile bawubonile umphumela wokuxilonga wekhithi yokuhlola ye-INNOVITA 2019-nCov.

Ngokungafani nama-reagents aziwa kakhulu e-nucleic acid e-Covid-19, i-INNOVITA isungule i-reagent entsha yokutholwa kwe-Covid-19.Enqubweni yokuhlola, i-antibody ye-lgM esigulini ingatholwa, futhi i-antibody ye-lgM ingatholwa ngosuku lwe-7 lokutheleleka kwesiguli noma ngosuku lwe-3 lwesiqalo, okuhlinzeka ngereferensi ebanzi yokuxilongwa komtholampilo.